Adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers as prognostic factors of early‐stage large‐cell neuroendocrine carcinoma

BACKGROUND: We investigated whether adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers affected survival of patients with the early stage of large‐cell neuroendocrine cancer. METHODS: This was a retrospective multicenter study including consecutive patients und...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreetti, Claudio, Ibrahim, Mohsen, Gagliardi, Antonio, Poggi, Camilla, Maurizi, Giulio, Armillotta, Domenico, Peritone, Valentina, Teodonio, Leonardo, Rendina, Erino Angelo, Venuta, Federico, Anile, Marco, Natale, Giovanni, Santini, Mario, Fiorelli, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977171/
https://www.ncbi.nlm.nih.gov/pubmed/35170859
http://dx.doi.org/10.1111/1759-7714.14287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977171/
https://www.ncbi.nlm.nih.gov/pubmed/35170859
http://dx.doi.org/10.1111/1759-7714.14287

Ejemplares similares